Macrophages are considered to contribute to chronic inflammatory diseases such as rheumatoid arthritis 1 . However, both the exact origin and the role of macrophages in inflammatory joint disease remain unclear. Here we use fate-mapping approaches in conjunction with three-dimensional light-sheet fluorescence microscopy and single-cell RNA sequencing to perform a comprehensive spatiotemporal analysis of the composition, origin and differentiation of subsets of macrophages within healthy and inflamed joints, and study the roles of these macrophages during arthritis. We find that dynamic membranelike structures, consisting of a distinct population of CX 3 CR1 + tissue-resident macrophages, form an internal immunological barrier at the synovial lining and physically seclude the joint. These barrier-forming macrophages display features that are otherwise typical of epithelial cells, and maintain their numbers through a pool of locally proliferating CX 3 CR1 − mononuclear cells that are embedded into the synovial tissue. Unlike recruited monocyte-derived macrophages, which actively contribute to joint inflammation, these epithelial-like CX 3 CR1 + lining macrophages restrict the inflammatory reaction by providing a tight-junctionmediated shield for intra-articular structures. Our data reveal an unexpected functional diversification among synovial macrophages and have important implications for the general role of macrophages in health and disease.
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Macrophages are considered to contribute to chronic inflammatory diseases such as rheumatoid arthritis 1 . However, both the exact origin and the role of macrophages in inflammatory joint disease remain unclear. Here we use fate-mapping approaches in conjunction with three-dimensional light-sheet fluorescence microscopy and single-cell RNA sequencing to perform a comprehensive spatiotemporal analysis of the composition, origin and differentiation of subsets of macrophages within healthy and inflamed joints, and study the roles of these macrophages during arthritis. We find that dynamic membranelike structures, consisting of a distinct population of CX 3 CR1 + tissue-resident macrophages, form an internal immunological barrier at the synovial lining and physically seclude the joint. These barrier-forming macrophages display features that are otherwise typical of epithelial cells, and maintain their numbers through a pool of locally proliferating CX 3 CR1
− mononuclear cells that are embedded into the synovial tissue. Unlike recruited monocyte-derived macrophages, which actively contribute to joint inflammation, these epithelial-like CX 3 
CR1
+ lining macrophages restrict the inflammatory reaction by providing a tight-junctionmediated shield for intra-articular structures. Our data reveal an unexpected functional diversification among synovial macrophages and have important implications for the general role of macrophages in health and disease.
The healthy synovial cavity is a fluid-containing sterile space that lacks immune cell trafficking. During inflammatory joint diseases such as rheumatoid arthritis, increasing numbers of mononuclear phagocytes and synovial fibroblasts are thought to contribute to an expanding synovial pannus that drives the destruction of articular cartilage and bone [2] [3] [4] . Previous work that addressed the role of monocytes and macrophages during arthritis accordingly suggested that these cells promote both the onset and the progression of joint inflammation 1, [5] [6] [7] [8] , a scenario that has substantially shaped our current view on the role of these cells during inflammatory disease in general.
More recent studies have questioned the concept that macrophages uniformly originate from blood monocytes, and have shown that certain subsets of macrophages populate organs during early development and subsequently self-sustain their numbers in a monocyte-independent manner [9] [10] [11] [12] . Individual subsets of such resident macrophages have distinct transcriptional and epigenetic signatures, which suggests that they have highly specialized and tissue-specific functions [13] [14] [15] [16] . These recent insights prompted us to question prevailing paradigms and to revisit the origin and function of synovial macrophages during homeostasis and inflammatory joint disease.
CX 3 CR1 is a chemokine receptor that is specifically used by mononuclear phagocytes and their precursors 11 . To visualize the spatial distribution of CX 3 CR1
+ macrophages and macrophages originating from CX 3 CR1
+ precursors, respectively, we performed confocal immunofluorescence microscopy and three-dimensional light-sheet fluorescence microscopy of optically cleared knee joints in Cx3cr1 cre Rosa26(R26)-tdTomato mice (Fig. 1a , b, Supplementary Video 1). This approach revealed membrane-like structures of synovial tdTomato + macrophages that formed a dense physical barrier between the synovial capillary network and the intra-articular space, thereby secluding the joint space from the exterior (Fig. 1b, 
c, Supplementary Videos 2-4). Analysis of ColVI
cre R26-tdTomato reporter mice showed that these macrophages formed the uppermost cellular layer and covered the lining of collagen VI-expressing synovial fibroblasts (Extended Data  Fig. 1a ). In Cx3cr1 GFP mice, we confirmed that such membrane-forming lining macrophages selectively expressed CX 3 CR1, stained positive for CD68 and F4/80, and constituted 40% of the total synovial macrophages under steady-state conditions. By contrast, interstitial synovial macrophages did not express CX 3 CR1 (Extended Data Fig. 1a, b) .
Next, we studied the response of macrophages during K/BxN serum-transfer arthritis (STA) and collagen-induced arthritis as mouse models of rheumatoid arthritis. The onset of inflammation resulted in a rapid change in the morphology and spatial orientation of CX 3 CR1 + macrophages that suddenly abrogated cell-cell contacts (Fig. 1d , Extended Data Fig. 1c -h, Supplementary Videos 5-7). Simultaneously, collagen VI-expressing fibroblasts started occupying the synovial surface (Extended Data Fig. 1f ) and Ly6G + polymorphonuclear leucocytes (PMNs) appeared within the intra-articular space. Dying PMNs were subsequently removed by lining macrophages that had acquired a palisade-like shape (Fig. 1d, Extended Data Fig. 1c-e) .
During embryonic development, we detected CX 3 CR1 + synovial lining macrophages by embryonic day (E)15.5 and E16.5, which indicates that synovial macrophage precursors derive from early embryonic haematopoiesis (Extended Data Fig. 2a ). Adult parabiotic wild-type mice that shared circulation with Cx3cr1 GFP mice displayed chimeric myeloid cell populations within the peripheral blood, but no detectable chimerism among CX 3 CR1
+ synovial lining macrophages (Fig. 2a ). These data suggested that, in the adult mouse, this subset of macrophages maintained its numbers independent of blood monocytes.
Analysis of Ki67 expression revealed no signs of proliferation within
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+ lining macrophages (Fig. 2b) , thus raising questions regarding their mechanism of repopulation and turnover. Notably, we detected clusters of proliferating Ki67
− interstitial cells within deeper layers of the synovial tissue (Fig. 2b) . The Ki67 signal decreased in upper cellular layers in which CX 3 CR1 expression simultaneously increased, suggestive of a pool of proliferating CX 3 CR1
− interstitial macrophages that contributed to the pool of CX 3 CR1
+ lining macrophages. Antibody-mediated staining of the M-CSF receptor (CSF1R) within the synovial tissue, as well as mice expressing a Csf1r promoter-driven GFP (Csf1r GFP mice), showed that only CX 3 CR1
− interstitial macrophages-and not CX 3 CR1 + lining macrophagesexpressed CSF1R on their surface (Extended Data Fig. 2b, c) . We therefore crossed R26-tdTomato mice with mice expressing a Csf1r promoter-driven and tamoxifen-dependent Cre recombinase (Csf1r creER R26-tdTomato), an approach that enabled fate mapping of all cells that had expressed CSF1R at a certain developmental stage. After the start of tamoxifen treatment, lining CX 3 CR1
+ macrophages acquired tdTomato expression only gradually over time, reaching 65% tdTomato + cells after 6 weeks. These data indicate that CX 3 CR1 + lining macrophages have a half-life of approximately five weeks and did indeed originate from local CSF1R-expressing CX 3 CR1
− interstitial macrophages (Fig. 2c, d ).
Additional characterization of parabiotic wild-type mice that shared circulation with DsRed-transgenic mice confirmed that, during steady state, both CX 3 CR1
+ lining macrophages and CX 3 CR1 − interstitial macrophages maintained their numbers independent of monocytes (Extended Data Fig. 2d-i) . Although blood-derived monocytes contributed to the pool of synovial macrophages during STA, this influx only partially accounted for the inflammation-induced increase in macrophage numbers (Fig. 2e, f, Extended Data Fig. 2j, k 
Fig. 1 | CX 3 CR1
+ lining macrophages form a dynamic membrane-like structure around the synovial cavity. a-d, Representative 3D lightsheet fluorescence microscopy (LSFM) and confocal laser scanning microscopy (CLSM) of knee joints of Cx3cr1 cre R26-tdTomato mice (LSFM, n = 10; CLSM, n =3). a, The spatial localization of synovial macrophages (tdTomato, red) and PMNs (Ly6G, green) are shown during steady state (autofluorescence (AF), grey). Arrowheads indicate the localization of the macrophage layer (tdTomato, red) at the border of the synovial cavity (sc). bm, bone marrow; m, meniscus. Scale bars, 500 µm (left), 100 µm (right). b, Top, LSFM analysis of the spatial arrangement of the synovial macrophage lining (tdTomato, red; arrowheads) and CD31 + endothelial cells (blue) along the synovial cavity in three dimensions (AF, grey). Scale bars, 100 µm. Bottom, high-resolution 3D reconstruction of a processed CLSM scan of the synovial macrophage lining (tdTomato, red; Phalloidin, green; DAPI, blue). Scale bar, 10 µm. c, Three-dimensional reconstruction of LSFM data of the spatial orientation of synovial macrophages (tdTomato, red) and CD31 + endothelial cells (blue) of the synovial capillary network (AF, grey). Scale bars, 100 µm. d, CLSM of the synovial membrane visualizing synovial macrophages (tdTomato, red) and PMNs (Ly6G, green) at the indicated time points upon the induction of K/BxN STA. Scale bars, 20 µm (top), 5 µm (bottom). ac, articular cartilage; st, synovial tissue.
Letter reSeArCH a gene encoding a tamoxifen-dependent Cre recombinase within the Cx3cr1 locus (Cx3cr1 creER R26-tdTomato mice). Tamoxifen treatment resulted in selective and continuous expression of tdTomato in the layer of CX 3 CR1 + synovial lining macrophages. A proportion of CX 3 CR1 + blood monocytes was initially marked after systemic tamoxifen treatment, but became rapidly replaced by newly generated tdTomato − monocytes. Induction of arthritis four weeks after a systemic tamoxifen pulse or a local tamoxifen injection enabled selective fate mapping of tissue-resident CX 3 CR1 + lining macrophages during steady state and inflammation, and therefore enabled discrimination from interstitial or monocyte-derived macrophages (Fig. 2g-i, Extended Data Fig. 3a-f ). In conjunction with 5-ethynyl-2′-deoxyuridine (EdU) labelling, this approach confirmed that-at the onset of arthritis-CX 3 CR1
+ lining macrophages changed their spatial orientation and morphology but maintained their position, and neither proliferated nor changed in number. By contrast, CX 3 CR1
− macrophages rapidly proliferated and accordingly increased in number (Fig. 2h-j, Extended Data Fig. 3f-h ).
Bulk RNA sequencing of sorted steady-state CX 3 CR1 + lining macrophages and CX 3 CR1
− interstitial synovial macrophages showed that they did indeed represent distinct macrophage populations, both of which are only distantly related to bone-marrow-derived macrophages (Fig. 3a, b , Extended Data Fig. 4a-e) . In addition, unbiased molecular profiling of total synovial CD45
+

CD11b
+
Ly6G
− mononuclear phagocytes by single-cell RNA sequencing (scRNA-seq) confirmed the presence of the defined cluster of differentiated CX3CR1
+ lining macrophages, which co-expressed immunegenes such as Trem2 or Vsig4 (Fig. 3c, d , Supplementary Table 1) . However, scRNA-seq also revealed an additional degree of heterogeneity among CX 3 CR1
− interstitial macrophages. A large number of interstitial CX 3 CR1 − macrophages expressed relatively high levels mRNAs encoding MHCII and aquaporin (AQP1), whereas another population of interstitial CX 3 CR1
− macrophages was characterized by the expression of Retnla (which encodes RELM-α) and additional genes-such as Mrc1 or Cd163-that have previously been implicated in the alternative activation of macrophages (Fig. 3c, d ). There was also a smaller population of interstitial Stmn1-expressing CX 3 CR1
− macrophages that were clustered primarily as a result of their high expression of cell-cycle-associated genes such as Cdk1; this suggests that they were not a distinct cellular population but instead were proliferating interstitial MHCII + and AQP1
− macrophages (Fig. 3c, d , Extended Data Fig. 4f, g ). Pseudotime analyses indicated that both RELM-α + macrophages and CX 3 CR1
+ lining macrophages were differentiated macrophages that originated from the cluster of proliferating MHCII
− interstitial macrophages (Extended Data Fig. 4h-j) . This analysis additionally suggested that the initial proliferation of interstitial MHCII + CX 3 CR1 − macrophages was followed by an upregulation of mRNAs encoding the transcription factors MAFB and MAF, which have previously been shown to interfere with macrophage proliferation 17 (Extended Data  Fig. 4j ). Fate mapping in tamoxifen-treated Csf1r creER R26-tdTomato mice confirmed that-in accordance with this pseudotime modelinterstitial MHCII + macrophages immediately responded with the expression of tdTomato, whereas interstitial RELM-α + macrophages and CX 3 CR1
+ lining macrophages only gradually acquired tdTomato expression over time (Extended Data Fig. 4k-m R26 -tdTomato mice at day 0 (n = 6), 2 (n = 5), and 5 (n = 6) after the induction of STA. Data are mean ± s.e.m.
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cells that had expressed RELM-α within the synovial lining (Extended Data Fig. 4n ) or cells that had expressed CX 3 CR1 within the interstitial synovial tissue (Fig. 2i) . As expected, continuous diphtheria toxin (DT)-mediated depletion of CSF1R-expressing synovial macrophages in Lysm cre CD115DTR mice resulted in the complete depletion of interstitial MHCII + macrophages, whereas the density of CX 3 CR1 + lining macrophages decreased only slowly with time. Cessation of DT treatment led to rapid repopulation of the pool of proliferating interstitial MHCII + macrophages, whereas the repopulation of CX 3 CR1 + lining macrophages was delayed (Extended Data Fig. 4o, p) . Together, these experimental datasets supported the scRNA-seq-based pseudotime model of a dynamic continuum within resident synovial macrophages, in which proliferating MHCII + CX 3 CR1 − interstitial macrophages further differentiate either into CX 3 CR1
+ lining macrophages or RELM-α + interstitial macrophages (Extended Data Fig. 5q ). scRNA-seq confirmed that the onset of STA resulted in the appearance of additional clusters of mononuclear phagocytes that displayed the signature of monocyte-derived macrophages; these clusters expanded during the progression of arthritis. These mostly Ccr2-and Ly6c2-expressing cells displayed a pro-inflammatory activation profile, including the expression of Il1b (Extended Data Fig. 5a , b and Supplementary Table 2 ). Tamoxifen-pulsed Cx3cr1 creER R26-tdTomato mice enabled us to fate map tdTomato-expressing CX 3 CR1
+ lining macrophages within the generated scRNA-seq datasets throughout the course of STA. This analysis showed that-despite their increasingly inflammatory microenvironment-lining macrophages stably maintained their immune-regulatory phenotype, including the expression of Trem2 and of high levels of receptors that mediate the clearance of apoptotic cells, such as Axl and Mfge8 (Extended Data Fig. 5b, c) . A comparison of available scRNA-seq datasets from human rheumatoid arthritis synovium 8 showed that the expression profiles of two of four recently described subsets of human synovial monocytes (SC-M2 and SC-M3) matched the profiles of mouse resident synovial macrophages, whereas the other two subsets of human synovial monocytes (SC-M1 and SC-M4) resembled mouse monocyte-derived synovial macrophages (Extended Data Fig. 5d ).
Notably, CX 3 CR1 + lining macrophages also displayed features that are otherwise typical of barrier-forming epithelial cells, and expressed mRNAs encoding tight-junction proteins such as JAM1 (F11r), ZO-1 (Tjp1) and claudin 5 (Cldn5), as well as genes involved in planar cell polarity, including Fat4 and Vangl2 (Extended Data Figs. 4a-e, 5b). Consistent with this, confocal immunofluorescence microscopy and transmission electron microscopy images showed the expression of tight-junction and gap-junction proteins, as well as the presence of definite tight junctions, adherens junctions, desmosomes and prominent cellular interdigitations at the cell-cell border of CX 3 CR1
+ lining macrophages (Extended Data Figs. 6, 7a-d) . The results of confocal immunofluorescence microscopy and flow cytometry of human synovial tissue confirmed a dense macrophage lining, consisting of closely associated TREM2
+ macrophages that also expressed tight-junction proteins (Extended Data Fig. 8a-c) . These TREM2 + MHCII − macrophages comprised 10-30% of the total human synovial macrophages during steady state in samples derived from patients with osteoarthritis, but were seemingly outnumbered by TREM2
− mononuclear phagocytes that dominated the disrupted synovial lining of patients with rheumatoid arthritis (Extended Data Fig. 8b-e) .
Tight junctions between synovial lining macrophages rapidly disintegrated both during STA and during human rheumatoid arthritis, correlating with the changing physical density of this macrophage network during the onset and resolution of inflammation ( Fig. 9b ). This inflammation-associated barrier breakdown occurred after the deposition of autoantibody-containing immune complexes, which were immediately ingested by CX 3 CR1
+ lining macrophages (Extended Data Fig. 9c, d ). Depletion of PMNs and Ly6C high inflammatory monocytes did not interfere with barrier breakdown, indicating that disintegration of tight junctions within the synovial macrophage lining resulted from an initial immune-complex-mediated activation of CX 3 CR1
+ lining macrophages and was independent of the recruitment of inflammatory myeloid cells (Extended Data Fig. 9e, f) . To investigate the role of tight-junction-expressing CX 3 CR1
+ macrophages during arthritis, we crossed Cx3cr1 cre mice with mice containing a Cre-inducible DT receptor (Cx3cr1 cre R26-iDTR mice), allowing for the DT-mediated depletion of CX 3 CR1
+ resident synovial lining macrophages. This protocol resulted in the additional depletion of a proportion of blood monocytes; however, with the exception of tissue-resident macrophages, they repopulated within 48 h (Fig. 4d , e, Extended Data Fig. 9g ). Magnetic resonance imaging on day 5 after DT injection confirmed that the selective absence of CX 3 CR1
+ macrophages indeed abolished the synovial barrier in healthy mice, which corresponded to the barrier breakdown observed during the onset of arthritis (Fig. 4f) . Both systemic and local depletion of CX 3 CR1
+ lining macrophages-as well as forced disintegration of tight junctions upon the injection of claudin 5 peptidomimetics-resulted in a disrupted barrier function, an early and exacerbated onset of arthritis and accelerated PMN influx ( Fig. 4g , Extended Data Fig. 9h-k) . Together, these data suggest that this subset of macrophages exerts an important immune-regulatory function by maintaining a physical and functional tight-junctionmediated barrier that secludes and protects intra-articular structures and thereby controls the onset of inflammation. Consistent with this, the tyrosine kinase inhibitor imatinib-which has been shown to stabilize the formation of tight junctions at the blood-brain barrier 18 was found to interfere with the onset of arthritis ( cre iDTR and iDTR control mice received 2 × 500 ng DT intraperitoneally 5 days before the administration of K/BxN serum. e, Representative bright-field fluorescence microscopy of the synovial lining on day 5 after the application of DT (phalloidin, green; F4/80, red; DAPI, blue). f, Normalized signal intensity curves from the dynamic-contrast-enhanced magnetic resonance imaging of synovial tissue from the knee joints of DT-treated mice at the indicated days of STA, over 90 measurements with intervals of 7 s in Cx3cr1 cre iDTR (n = 8 knee joints) and iDTR control mice (n = 10 knee joints). Data are mean ± s.e.m. of AUC, two-tailed Student's t-test; day 0, ***P = 0.0003; day 1, ***P = 0.0001. g, Clinical course of STA, including AUC of the corresponding clinical index, in Cx3cr1 cre iDTR (n = 10) and iDTR control (n = 9) of DT-treated mice. Data are mean ± s.e.m.; two-tailed Mann-Whitney U-test for clinical index with *P ≤ 0.05 and **P ≤ 0.01; two-tailed Student's t-test for AUC, **P = 0.0093. h, Clinical course of STA, including AUC of the corresponding clinical index, in C57BL/6 wild-type mice treated with imatinib (80 µg kg −1 , oral gavage, twice daily, n = 4) or vehicle (n = 6) starting one day before the induction of STA. Mean ± s.e.m.; Mann-Whitney U-test for clinical index with *P ≤ 0.05 and **P ≤ 0.01; two-tailed Student's t-test for AUC with ***P = 0.0001. i, Clinical course of STA, including AUC of the corresponding clinical index, in LysM cre CD115DTR (n = 7) and CD115DTR control mice (n = 10) treated with DT (500 ng per mouse intraperitoneally) starting one day before STA induction followed by a daily intraperitoneal injection of 100 ng DT. Mean ± s.e.m.; Mann-Whitney U-test for clinical index with *P ≤ 0.05; two-tailed Student's t-test for AUC, *P = 0.0417.
renewing and protective tight-junction-mediated macrophage barrier has important implications for our general understanding of the role of macrophages in health and disease (Extended Data Fig. 10 ). Other tissue-resident macrophages might use similar mechanisms to fulfil related gatekeeping functions, thereby determining the onset and resolution of inflammation, modulating host defence 19 , preventing neutrophil-driven inflammatory tissue damage 20 or potentially interfering with an anti-tumour immune response.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at https://doi.org/10.1038/s41586-019-1471-1.
Letter reSeArCH
Methods
For additional information on materials used, see Supplementary Table 3 . Ethical compliance. We complied with all relevant ethical regulations in terms of animal experiments and human samples in this study. All animal experiments conducted at the University of Erlangen were performed in accordance with German guidelines and laws, were approved by local animal ethic committees of the Regierung von Mittelfranken and were conducted according to the guidelines of the Federation of European Laboratory Animal Science Associations. Parabiosis experiments were approved by the Animal Care and Ethics Committee of the Centro Nacional de Investigaciones Cardiovasculares and local authorities.
Synovial biopsies were obtained from knee joints of patients diagnosed with osteoarthritis or rheumatoid arthritis. Patients with rheumatoid arthritis fulfilled the 2010 EULAR/ACR criteria of rheumatoid arthritis. All patients were ≥18 years of age. Patients with osteoarthritis were recruited at the Department of Trauma Surgery, University Hospital Erlangen and patients with rheumatoid arthritis were recruited at the Department of Internal Medicine 3 -Rheumatology and Immunology, University Hospital Erlangen. All patients signed an informed consent form, which was approved by the local ethics committee of the University Hospital Erlangen. Mice. For all experiments, mice of both sexes were used. For details regarding mouse strains, see Supplementary 
tm9(CAG-tdTomato)Hze /J (tdTomato), C57BL/6-Tg(Csf1r-HBEGF/mCherry)1Mnz/J (CD115DTR) and B6.129P-Cx3cr1tm1Litt/J (Cx3cr1 GFP ) mice were purchased from Jackson Laboratories. These mice were bred and housed at the animal facilities of the University of Erlangen under specific-pathogen-free conditions. ColVI cre mice were generated in the laboratory of G. Kollias and have previously been described 21 . Retnla cre R26-tdTomato mice were generated in the laboratory of D. Vöhringer 22 .
In vivo treatments and arthritis induction. K/BxN STA was induced by the injection of K/BxN serum collected from arthritic K/BxN mice. Clinical development of arthritis was evaluated using a clinical index ranging from 0 (minimum) to 16 (maximum), which represents a cumulative score of 0 to 4 for each paw, with 0 = no signs of inflammation; 1 = minor swelling and reddening of a paw, or affecting only single digits; 2 = moderate swelling and erythema, or affecting multiple digits per paw; 3 = severe swelling and erythema affecting the whole paw; 4 = maximum swelling and erythema. Measurements of hind-paw swelling were conducted using dial thickness gauges (Peacock).
Cx3cr1 creER tdTomato mice were treated systemically with 4 mg tamoxifen dissolved in peanut oil intraperitoneally (i.p.) twice within 48 h. Csf1r creER R26-tdTomato mice were fed with tamoxifen-containing food (400 mg kg −1 tamoxifen citrate, Envigo) for 5 days, 4 weeks or 6 weeks. Local administration of (Z)-4-hydroxytamoxifen (Sigma-Aldrich, H7904) was performed by intra-articular injection of 25 µl of (Z)-4-hydroxytamoxifen (2 mM) dissolved in PBS/4% ethanol into the right knee joint. Five days after injection, K/BxN serum transfer arthritis was induced. Mice were analysed seven days after the induction of arthritis.
For systemic administration of DT, Cx3cr1 cre iDTR mice received 500 ng DT per mouse i.p. on 2 consecutive days, beginning 6 days before the induction of STA. Local depletion of macrophages in Cx3cr1 cre iDTR mice was induced by the injection of 50 ng DT in 50 µl PBS directly into the hind paw 3 days before the induction of STA. The contralateral hind paw was injected with PBS and served as a control.
LysM cre CD115DTR mice received a single dose of 500 ng DT per mouse (i.p.) 1 day before the induction of arthritis followed by daily injections of 100 ng DT per mouse (i.p.). To study the depletion of synovial macrophages in LysM cre CD115DTR mice under healthy conditions, 500 ng DT per mouse was injected intraperitoneally 3 times a week until day 10.
The claudin peptidomimetics 23 (C5C2, sequence SSVVQSTGHMQSKV YESVLALSAEVQAAR-NH2) and scrambled variant (C5C2scr, AHLVRSVSD VMQSQTGKTSESYSAVQLVA-NH2) were dissolved in PBS and injected intravenously (i.v.) (3.5 µmol kg ) was given orally twice a day, starting one day before the induction of STA. Imatinib was dissolved in aqueous vehicle solution containing 0.5% (hydroxypropyl)cellulose and 0.05% TWEEN 80. K/BxN serum IgG was isolated with protein-G Gravi-Trap (GE Healthcare, 28-9852-55) and labelled using SAIVI Alexa Fluor 647 Antibody/Protein 1 mgLabelling Kit. Labelled IgGs were injected i.v. with K/BxN serum at a ratio of 1:4.
Collagen-induced arthritis was induced as previously described 24 . In brief, C67BL/6 mice were immunized by intradermal injection of an emulsion of 200 µg of chicken type II collagen (Sigma-Aldrich, C-930) with 250 µg heat-inactivated Mycobacterium tuberculosis H37RA in incomplete Freund's adjuvant (SigmaAldrich, F5506) at day 0 and day 21.
Depletion of neutrophils and Ly6C + monocytes was performed by i.v. injection of 200 µg InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1) (clone: RB6-8C5, Bio X Cell, BP0075) one day before K/BxN serum transfer. InVivoPlus rat IgG2b isotype control, anti-keyhole limpet haemocyanin (200 µg, i.v., clone: LTF-2, Bio X Cell, BP0090) served as control.
The severity of both K/BxN STA and collagen-induced arthritis was scored in a blinded manner. Mice were not randomized before the experiment. Parabiosis. Parabiosis was performed following a previously described procedure 25 . Mice were shaved under anaesthesia at the corresponding lateral region and incisions were made from the olecranon to the knee joint of each mouse. Olecranons and knee joints of partner mice were tied together by a single 5-0 polypropylene suture. Dorsal and ventral skins were stitched up forming a continuous suture. Finally, each mouse received a single injection of buprenorphine subcutaneously. Analysis was performed as indicated six or nine weeks after surgery. The tissue chimerism was calculated as the quotient of the ratios of partner-derived macrophages of synovial joints and the ratio of partner-derived monocytes in the blood as quantified by flow cytometry. A tissue-to-blood chimerism of one thus represents an equal ratio between blood and tissue. Flow cytometry and fluorescence-activated cell sorting. For isolation of synovial macrophages, hind paws were dissected by removing skin, muscle and tendons. Cells were dissociated by incubation for 45 min in a digestion medium consisting of RPMI medium, 10% heat-inactivated fetal calf serum (FCS), collagenase (2 mg ml −1 ) from Clostridium histolyticum (Sigma-Aldrich, C5138-1G) and 0.03 mg ml −1 DNase (Sigma-Aldrich, 9003-98-9). After washing with PBS containing 2% heat-inactivated FCS and 2 mM EDTA, cells were blocked with 10% rat serum in PBS for 10 min at room temperature and stained with fluorophore-conjugated antibodies for 20 min at 4 °C. After washing with PBS, cells were resuspended in FACS buffer (PBS, 2% FCS). EdU, which was injected intraperitoneally (50 mg kg −1 ) 4 h before collecting the cells, was detected using the EdU base click EdU-Flow Cytometry Kit 488 (BCK-FC488-100).
Human synovial tissue was dissociated in digestion medium containing RPMI medium, 10% heat-inactivated fetal calf serum (FCS), collagenase (2 mg ml −1 ) from C. histolyticum (Sigma, C5138-1G) and 0.03 mg ml −1 DNase (Sigma, 9003-98-9) at 37 °C for 45 min. After washing with PBS, cells were incubated with Zombie Aqua (1:1,000, BioLegend) for 15 min at room temperature. Dissociated cells were fixed with 4% PFA/PBS, incubating for 15 min at room temperature. After washing with 1% BSA/PBS, cells were resuspended in saponin-based permeabilization buffer containing the following antibodies: CD11b-AF488, MHC II-PE, CD14-PeCy7, CD45-AF700, CD1c-PerCP/Cy5.5, CD20-BV421, CD15-BV421 and TREM2-APC, overnight at 4-8 °C.
Flow + lining and CX 3 CR1 − macrophages. For generating BMDMs, bone marrow cells were isolated from femurs of C57BL/6 mice and cultured for one day in DMEM (10% FCS, 1% penicillin-streptomycin). Non-adherent macrophage precursors were cultivated and differentiated to macrophages for 5 days in M-CSF-conditioned DMEM medium (10% FCS, 1% penicillin-streptomycin). Isolation of RNA was performed using the RNeasy Mini kit (Qiagen, 74104). Libraries were subjected to single-end sequencing (101 bp) on a HiSeq-2500 platform (Illumina). The obtained reads were converted to .fastq format and demultiplexed using bcl2fastq v2.17.1.14. Quality filtering was performed using cutadapt v. 1.15; then reads were mapped against the mouse reference genome (Ensembl GRCm38, release 91) using the STAR aligner v.2.5.4a 26 , and a STAR genome directory created by supplying the Ensembl gtf annotation file (release 91). Read counts per gene were obtained using featureCounts program v.1.6.1 27 and the Ensembl gtf annotation file. The subsequent analyses were performed using R v.3.5.0. In particular, differential expression analysis was performed with the DESeq2 package v.1.20.0 28 and plots were generated with the ggplot2_2.2.1 package.
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Quantitative real-time PCR of sorted CX 3 CR1
+ macrophages and BMDMs. RNA of sorted GFP + macrophages from Cx3cr1 GFP mice and BMDMs was isolated using the RNeasy Mini kit (Qiagen, 74104). Reverse transcription of total RNA was performed with human leukaemia virus reverse transcriptase using the Gene Amp RNA PCR kit (Applied Biosystems) and oligo(dT) 16 primers (Invitrogen). Quantification of gene expression was performed as previously described 29 . The following primer sequences were used: β-actin: TGT CCA CCT TCC AGC AGA TGT (sense), AGC TCA GTA ACA GTC CGC CTA GA (antisense); ZO-1: GCT AAG AGC ACA GCA ATG GA (sense), GCA TGT TCA ACG TTA TCC AT (antisense); claudin 5: TTA AGG CAC GGG TAG CAC TCA CG (sense), TTA AGG CAC GGG TAG CAC TCA CG (antisense), claudin 10: TGG TGT GTG GTG TTG GAG GGT TTG G (sense), TGG AAG GAG CCC AGA GCG TTA CCT G (antisense) 30, 31 .
Single-cell sequencing of sorted myeloid cells of different stages of arthritis.
Sorted CD45
+
CD11b
+
Ly6G
− synovial cells of hind paws of mice at steady state (day 0) and at different stages of K/BxN STA (day 1, day 2 and day 5 after serum transfer) were subjected to 10x Chromium Single Cell 3′ Solution v2 library preparation according to the manufacturer's instructions. Library sequencing was performed on an Illumina HiSeq 2500 sequencer to a depth of 100 million reads each. Reads were converted to .fastq format using mkfastq from cellranger 2.1.0 (10x Genomics). Reads were then aligned to the mouse reference genome (mm10, Ensembl annotation release 91) including the additional sequence and feature annotation for tdTomato. Alignment was performed using the count command from cellranger 2.1.0 (10x Genomics). Primary analysis, quality control filtering (gene count per cell, unique molecular identifier count per cell, percentage of mitochondrial transcripts), clustering, cell-cycle phase scoring based on canonical markers and regression, identification of cluster markers and visualization of gene expression were performed using the Seurat (v.2.3) 32 package for R. Construction of single-cell trajectories, identification of genes changing as a function of pseudotime and clustering of genes by pseudotemporal expression patterns were performed using the Monocle 2 package for R. Pseudotime calculations were performed on the top 1,000 differentially expressed genes between clusters 33, 34 . For gene ontology enrichment analysis of biological processes, the PANTHER Statistical Overrepresentation Test (http://www.pantherdb.org) was used. Cryo-sectioning of mouse knee joints. Mouse long bones were fixed in 4% PFA/PBS (pH 7.4) for 12 h at 4-8 °C, incubated for 10 days in decalcification buffer (14% EDTA free acid, NH 4 OH, pH 7.2) and embedded in OCT Compound (Sakura Finetek). A Leica CM 3050 S cryostat and Cryofilm Type 2C(9) (C-MK001-A2, Section-Laboratory) were used for the generation of 7-µm-thick histological sections. Histological immunofluorescence staining. For staining cryo-sections of mouse knee joints, samples were blocked with rat serum or 0.2% BSA and permeabilized with 0.1% saponin in PBS for 1 h at room temperature. For immunofluorescence staining, the antibodies listed in Supplementary Table 3 were used. Staining was performed for 4 h at room temperature or overnight at 4 °C using the indicated antibodies diluted in blocking solution. Unbound primary antibodies were washed off with DPBS and unlabelled primary antibodies were counterstained with donkey anti-Rabbit IgG AF488 or AF647 antibody in blocking solution for 4 h at room temperature and washed with DPBS. Joint sections were stained with DAPI or SYTOX Blue by incubating samples for 10 min (DAPI) or 1 h (SYTOX Blue) at room temperature. Samples were washed three times with DPBS, once with water for injection, and embedded onto a coverslip with Dako Fluorescence Mounting Medium. Bright-field fluorescence microscopy of histological samples. Histological joint samples were imaged with an upright Nikon Eclipse Ni-U microscope, using a 10× (numerical aperture (NA) 0.30), 20× (NA 0.50) or 40× (NA 0.75) CFI Plan Fluor objective for varying magnifications. The halogen lamp excitation light (of wavelength λ ex ) as well as the emitted light (λ em ) was filtered specifically according to individual excitation/emission profiles: DAPI λ ex : 390/18 nm and λ em : 460/60 nm, fluorescein isothiocyanate (FITC)/AF488 λ ex : 475/35 nm and λ em : 530/43 nm, tdTomato/AF594 λ ex : 542/20 nm and λ em : 620/52 nm, AF647 λ ex : 628/40 nm and λ em : 692/40 nm. The generated data were processed with Imaris software. Confocal laser scanning microscopy of histological samples. For high-magnification imaging of histological joint sections, a Leica TCS SP 5 II confocal microscope with acousto-optic tunable filter and acousto-optical beam splitter, and hybrid detector (HyD) on a DMI6000 CS frame was used. Imaging of coverslip-embedded samples was performed using an HCX PL APO 100× oil objective with a NA of 1.44. Fluorescence signals were generated via sequential scans, exciting tdTomato using a diode-pumped solid-state laser at 561 nm and detecting with a HyD at 600-650 nm. The second sequence for visualizing Alexa Fluor 488 or FITC-labelled staining included an argon laser at 488 nm for excitation and a HyD detector at 500-550 nm. A third imaging sequence involved a simultaneous excitation of SYTOX Blue with a 458-nm argon laser and of Alexa Fluor 647 staining with a 633-nm helium-neon laser. SYTOX Blue was detected by HyD at 470-520 nm and Alexa Fluor signals were detected by HyD at 650-700 nm. Generated images were deconvoluted with Huygens Professional and 3D-reconstructed with Imaris software. Spinning disk confocal microscopy of histological samples. For spinning disk confocal microscopy of histological joint sections, an inverted Zeiss Spinning Disc Axio Observer.Z1 with a Yokogawa CSU-X1M 5000 spinning disk unit, a LD C-Apochromat 63× water immersion objective (NA 1.15) and an Evolve 512 EMCCD camera was used. Fluorescence signals were excited and detected as follows: DAPI λ ex : 405 nm DPSS laser and λ em : 445/50 nm BP filter, AF488 λ ex : 488 nm DPSS laser and λ em : 525/50 nm BP filter, tdTomato λ ex : 561 nm DPSS laser and λ em : 605/70 nm BP filter. Acquired images were processed via Zen Blue 2.3 image acquisition software. Optical clearing of mouse joint samples. Optically cleared samples for lightsheet fluorescence microscopy were generated as previously described 35 . In detail, mice received 2.5 µg Ly6G-AF647 or CD31-AF647 in PBS i.v. and were euthanized after 1 h. Mice were perfused with 5 mM EDTA/PBS and perfusion-fixed with 4% PFA/PBS (pH 7.4). Knee joints were relieved from muscle tissue and post-fixed in 4% PFA/PBS (pH 7.4) for 4 h at 4-8 °C with gentle shaking. Tissue fixation was followed by dehydration. Tissue dehydration was performed by increasing the proportion of ethanol according to the following series: 50%, 70% and two consecutive incubations with 100% ethanol each. The 50% and 70% ethanol solutions were generated by diluting 100% ethanol with water for injection, and their pH values were adjusted to 9.0 using NaOH. All tissue dehydration steps were performed at 4-8 °C in gently shaking 5 ml tubes. After tissue dehydration, joint samples were transferred to ethyl cinnamate and incubated at room temperature for 6 h. LSFM of optically cleared samples. LSFM of optically cleared mouse knee joints was performed with a LaVison BioTec Ultramicroscope II including an Olympus MVX10 zoom body (Olympus), a LaVision BioTec Laser Module, and an Andor Neo sCMOS Camera with a pixel size of 6.5 µm. Detection optics with an optical magnification range from 1.263 to 12.63 and a NA of 0.5 were used.
For visualization of general tissue morphology, a 488-nm optically pumped semiconductor laser (OPSL) was used to generate autofluorescent signals. For tdTomato excitation, a 561-nm OPSL and for CD31-AF647 or Ly6G-AF647 excitation, a 647-nm diode laser was used. Emitted wavelengths were detected with specific detection filters: 525/50 nm for autofluorescence, 620/60 nm for tdTomato, and 680/30 nm for CD31-AF647 or Ly6G-AF647. The optical zoom factor of the measurements varied from 1.26 to 8 and the light-sheet thickness ranged from 5 to 10 µm. Three-dimensional lining density analysis. The density of the synovial lining was analysed by a volumetric ratio of tdTomato + lining macrophages to synovial tissue. Three-dimensional reconstruction of LSFM-scanned mouse knee joints was performed using Imaris software. The synovial lining was optically separated from the joint tissue by manual surface rendering. Volumes of the isolated synovial lining tissue and tdTomato + lining cells were fully automatically rendered by the Imaris volume rendering tool with a size threshold of 5 µm for tdTomato + cells and 10 µm for synovial tissue. The percentage lining density was calculated from the ratio of cell and tissue volumes. Magnetic resonance imaging. Magnetic resonance imaging (MRI) data were acquired using the ClinScan 70/30 7 T MRI System (Bruker) and a RatBrain 1H-Surface Coil (Bruker). Before measurement, mice were anaesthetized and a tail-vein catheter was placed for the injection of contrast agent during measurement. The body temperature was kept constant with a heating blanket and the respiration rate was monitored constantly. Anaesthesia was maintained with isoflurane. Dynamic contrast-enhanced (DCE) MRI was conducted using a fast low angle shot (FLASH) sequence with repetition time (TR)/echo time (TE): Gadovist, Bayer) was injected after 40 s over a time period of 10 s. Sagittal and transverse T1-weighted images were acquired after running the DCE sequence with the following specifications: voxel size: 0.078 × 0.078 × 0.7 mm, TR/TE: 500 ms/9 ms, matrix 448 × 448. The mean contrast agent enrichment over time in the synovial tissue set as region of interest was analysed using Horos software (https://horosproject.org/). Transmission electron microscopy. Mouse knee joints were fixed in ITO fixation solution containing 2.5% glutaraldehyde (Roth, 4157.1), 2.5% paraformaldehyde (Roth, 0335.3), 0.1 M cacodylate buffer (Roth, 5169.2) and 0.3% picric acid dissolved in phosphate-buffered saline (pH 7.3) for two days, decalcified in cacodylate buffer (0.1 M) containing 14% EDTA for two weeks and finally embedded in Epon. Ultra-thin sections (Microtome, Reichert Ultracut S) of 50 nm were contrasted with uranyl acetate and lead(ii) acetate trihydrate and finally imaged with a transmission electron microscope (JEM 1400 Plus, Jeol).
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Statistics and reproducibility. For calculations of statistical significance, GraphPad Prism 5 was used. Data are presented as mean ± s.e.m. and were analysed using the two-sided Student's t-test, the Mann-Whitney U-test or the Kruskal-Wallis H-test with Dunn's multiple comparisons test as post hoc procedure unless stated otherwise. P values less than 0.05 were considered significant. LSFM of Fig. 1a is representative of ten individual mice. Experiments in Fig. 1b, c were performed three times. Bright-field microscopy (BFM), CLSM and LSFM images of Fig. 1d and Extended Data Fig. 1c-e 
Data availability
The data that support the plots within this paper and other findings of this study are available from the corresponding author upon request. The bulk and single-cell RNA-seq data are available as part of the Gene Expression Omnibus (GEO) SuperSeries GSE134691. . DsRed expression discriminates the origin. f, Representative BFM of the synovial membrane of knee joints of a wild-type mouse sharing circulation with a DsRed mouse, six weeks after establishment of parabiosis (n = 3; DsRed, red; F4/80, green). Scale bars, 25 µm. g, BFM images of parabiotic wild-type (top) and DsRed (bottom) mice after nine weeks of parabiosis. In the wild-type mice, DsRed + partner-derived macrophages are visible in the bone marrow (bm), but not detected in the macrophage (F4/80, green) lining layer. Scale bars, 25 µm. h, Flow-cytometric analysis of the percentage of partner-derived blood monocytes and synovial macrophages of DsRed/wild-type parabionts after 9 weeks of parabiosis. Mean ± s.e.m. Blood, n = 8; synovial joint, n = 8. i, Chimerism ratio of blood monocytes and synovial macrophages in DsRed/wild-type parabionts after six weeks and nine weeks of parabiosis, calculated as the quotient of content of partner-derived tissue macrophages to partner-derived blood monocytes. A chimerism ratio of one represents the chimerism observed in blood monocytes. Mean ± s.e.m. Monocytes 6 weeks, n = 6; synovial macrophages 6 weeks, n = 6; monocytes 9 weeks, n = 4; synovial macrophages 9 weeks, n = 8. j, k, Flow-cytometric analysis of parabiotic hind paws of DsRed/wild-type parabionts at the indicated time points of K/BxN serum transfer arthritis. Data presented show the percentage of partner-derived PMNs (k) and monocytes/macrophages (l) within the blood circulation and the synovial tissue and are used to calculate the individual chimerism of tissue-and blood-derived cells. Mean ± s.e.m. For j, blood day 0 n = 6; synovial tissue day 0, n = 6; blood day 5, n = 8; synovial tissue day 5, n = 7. For k, blood day 0, n = 6; synovial tissue day 0, n = 5; blood day 5, n = 7; synovial tissue day 5, n = 8. Fig. 3 | Fate mapping of synovial lining macrophages  during arthritis. a, Gating strategy creER tdTomato mice four weeks after systemic tamoxifen pulse (d) and five days after local injection of (Z)-4-hydroxytamoxifen (e) at day 0 and day 7 after the induction of K/BxN STA showing selective tdTomato (red) R26 -tdTomato mice 4 weeks upon tamoxifen pulse at day 0, 2 and 5 after induction of STA. Mean ± s.e.m. Day 0, n = 6; day 2, n = 5; day 5, n = 6. Fig. 4 | Transcriptional profiling of steady- The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
Extended Data
expression in synovial lining macrophages. The smaller graphs to the right in e show the absence of tdTomato expression in blood monocytes after local (Z)-4
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code Data collection Leica TCS SP 5 II CLSM data were collected using Las AF software version 2.7.3.9723. Spinning Disc Confocal Microscopy (SDCM) was eprfomred by using a Zeiss Spinning Disc Axio Observer.Z1 and images were collected via the Zen Blue image aquisition software Version 2.3. Light sheet fluorescence microscopy (LSFM) data were generated using an Ultramicrospe II (LaVision BioTech GmbH) and collected with Imspector software Version 5.1.304. MRI scans were performed using a ClinScan 70/30 7 Tesla MRI System (Bruker). Flow cytometry data and cell sorting data were aquired by using a CytoFLex S (Beckman Coulter) and a MoFlo XDP (Beckman Coulter) system.
Individual settings for data acquisitions via the systems listed above are described in detail in the experimental procedures.
Data analysis CLSM and SDCM data were processed and analysed using huygens professional software Version 17.10 (Scientific Volume Imaging), Imaris software Version 9.1 (Bitplane) and Image J software Version 1.8.0_112. LSFM data were processed using Imaris software Version 9.1 (Bitplane) and Image J software version 1.8.0_112. MRI data were processed via Horos LGPL Version 3.0. Flow cytometry data and cell sorting data were analyzed via the Summit Software System, MacsQuantify (Miltenyi Biotec, Version 2.5), CytExpert (Beckman Coulter, Version 2.2.0.97), FlowJo (FlowJo, Version 7.6.5), and Kaluza software (Beckman Coulter, Version 1.5a). Statistical data analysis was performed with GraphPad Prism 5.
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Differential expression analysis was performed with the DESeq2 package v.1.20.0 and volcano plots were generated with ggplot2 package in R software. For single cell RNA sequencing analysis CellRanger 2.1.0, FastQC v0.11.7, the Seurat (Version 2.3) package for R and Monocle 2 package were used.
All data analysis strategies and softwares are described prescisely in the experimental procedures and supplementary 
Replication
Minimum three independent measurements per experiment were performed and successfully confirmed results.
Randomization Experimental groups were randomly allocated. Treated groups were housed together with control groups.
Blinding
Data analysis was performed in a blinded fashion. The results were confirmed by two investigators, who analyzed the blindet data independently.
Reporting for specific materials, systems and methods All mice were housed under "specific pathogen-free" (SPF) conditions at the animal facilities of the University of Erlangen, Germany. Male and female mice at an age of 8-18 weeks were used.
Wild animals
This study does not include wild animals.
Field-collected samples
This study does not include field-collected samples.
Human research participants
Policy information about studies involving human research participants
Population characteristics
Synovial biopsies were obtained from knee joints of patients diagnosed with osteoarthritis (OA) and rheumatoid arthritis (RA), respectively. RA patients fulfilled the 2010 EULAR/ACR criteria of RA. All patients were ≥ 18years of age.
Recruitment
OA patients were recruited at the Department of Trauma Surgery, Universitätsklinikum Erlangen and RA patients were recruited at the Department of Internal Medicine 3 -Rheumatology and Immunology, Universitätsklinikum Erlangen. All patients signed an informed consent.
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation
Sample preparation is described in detail in the supplemental experimental procedures.
Instrument
Flow cytometry was performed with a CytoFLex S, Beckman Coulter. Sorting of cells was performed with a MoFlo XDP, Beckman Coulter.
Software
Flow cytometry data and cell sorting data were analyzed via the Summit Software System, CytExpert, FlowJo, and Kaluza software.
Cell population abundance Purity of sorted cells was confirmed by flow cytometry analysis.
Gating strategy FACS strategies are provided in detail in the extended data and supplementary experimental procedures.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
